Niagen Bioscience, Inc. (NAGE) Stock Analysis

Niagen Bioscience, Inc. (NAGE) is a publicly traded company in the HEALTHCARE sector. It trades at $3.54, carries a market capitalization of $287.52M, a price-to-earnings ratio of 17.19. This page summarizes the public market data, fundamentals, and frequently asked questions for NAGE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.54
• Market Cap: $287.52M
• P/E Ratio: 17.19
• EPS: $0.21
• 52-Week High: $14.69
• 52-Week Low: $3.57

Market Sentiment

Niagen Bioscience, Inc. currently has a Bullish sentiment score of 0.43.

About Niagen Bioscience, Inc.

Niagen Bioscience, Inc. is an innovative bioscience firm based in Los Angeles, California, focused on advancing healthy aging and improving quality of life through cutting-edge research in cellular health and metabolic science. The company develops and markets products aimed at promoting vitality and longevity, capitalizing on the increasing global emphasis on health and wellness. With its strong commitment to scientific excellence and a growing portfolio of pioneering solutions, Niagen is st...

GNG Research Analysis

GNG Research scores Niagen Bioscience, Inc. (NAGE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NAGE.

Frequently Asked Questions

Does NAGE pay dividends?

Niagen Bioscience, Inc. (NAGE) does not currently pay a regular dividend.

What is NAGE's P/E ratio?

Niagen Bioscience, Inc. has a price-to-earnings (P/E) ratio of 17.19.

What is NAGE's market cap?

Niagen Bioscience, Inc. (NAGE) has a market capitalization of $287.52M with a current stock price of $3.54.